JDJoanne Droney

Joanne Droney

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joanne Droney has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acceptability, usability and safety for lay carer preparation and administration of subcutaneous medications at home: a mixed-methods user-testing study

    by David Sunkersing, Leila Shepherd, Calandra Feather, Ivor Williams, Imogen Eastwood, Joanne Droney, Bryony Dean Franklin, Bee Wee, Lisa O’HAra, Ara Darzi, et al.

    Background: Many people approaching the end of life express a preference to remain and die at home, yet achieving this remains challenging. Delays in symptom control, particularly for breakthrough symptoms requiring subcutaneous medication, can contribute to distress and avoidable hospital admissions. Training family carers to prepare and administer subcutaneous medications may help address these challenges, but concerns remain regarding acceptability, usability, and safety. Aim: To evaluate, using a mixed-methods user-testing approach, the acceptability, usability, task performance, and safety of the Palliate intervention, a structured training programme designed to support lay carers in preparing and administering subcutaneous medications at home. Methods: A mixed-methods user-testing study was conducted with 30 participants randomised to one of three versions of the Palliate intervention. Participants were scheduled to complete simulated medication-administration scenarios at two visits under observation. Acceptability was assessed using a Theoretical Framework of Acceptability (TFA)-informed questionnaire, usability using the System Usability Scale (SUS), and task efficiency via completion time. Medication, administration and documentation errors and user safety incidents were recorded descriptively. Qualitative free-text responses were analysed using a TFA-informed content analysis to explore perceived barriers and opportunities. Results: Acceptability of the Palliate intervention was high across all versions and visits. Mean SUS scores exceeded the established average benchmark of 68 at both visits, with no significant change over time. Errors occurred at Visit 1 (in 23% of participants) but not at Visit 2, and median task completion time decreased between visits, although paired analysis indicated significantly longer completion times at Visit 2 ( p = 0.016). Three needle-stick injuries were observed; these were not associated with medication errors. Conclusion: Under simulated conditions, the Palliate intervention demonstrated high acceptability and usability, with errors observed at Visit 1 but not at Visit 2. These findings support further clinical evaluation of Palliate with family carers in real-world end-of-life care settings.

  • Open Access

    Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral “Triggers” Tool for outpatients with cancer

    by Laila Kamal, Yuki Kano, Anna-Marie Stevens, Kabir Mohammed, Natalie Pattison, Margaret Perkins, Sanjay Popat, Charlotte Benson, Ollie Minton, Diane Laverty, et al.

    Purpose To evaluate the use, acceptability, and experience of a seven-item palliative care referral screening tool in an outpatient oncology setting. Methods A two-phase convergent parallel mixed-methods study. Patient participants who met any of the “Royal Marsden Triggers Tool” criteria were compared with those who did not in terms of demographic data, palliative care needs (Integrated Palliative Outcome Scale, IPOS) and quality of life indicators (EORTC-QLQ-C30). In-depth interviews were carried out with patients and oncology staff about their views and experience of the “Royal Marsden Triggers Tool”. Qualitative and quantitative data were triangulated at data interpretation. Results Three hundred forty-eight patients were recruited to the quantitative phase of the study of whom 53% met at least one of the Triggers tool palliative care referral criteria. When compared with patients who were negative using the Triggers tool, “Royal Marsden Triggers Tool” positive patients had a lower quality of life (EORTC QLQ-C30 Global Health Status scale (p < 0.01)) and a higher proportion had severe or overwhelming physical needs on IPOS (38% versus 20%, p < 0.001). Median survival of “Royal Marsden Triggers Tool” positive patients was 11.7 months. Sixteen staff and 19 patients participated in qualitative interviews. The use of the tool normalised palliative care involvement, supporting individualised care and access to appropriate expertise. Conclusion The use of a palliative care referral tool streamlines palliative care within oncology outpatient services and supports teams working together to provide an early holistic patient-centred service. Further research is needed to evaluate the effectiveness and feasibility of this approach.


  • Open Access

    Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral “Triggers” Tool for out-patients with cancer

    by Laila Kamal, Yuki Kano, Anna-Marie Stevens, Kabir Mohammed, Natalie Pattison, Margaret Perkins, Sanjay Popat, Charlotte Benson, Ollie Minton, Diane Laverty, et al.

    Purpose: To evaluate the use, acceptability, and experience of a seven-item palliative care referral screening tool in an outpatient oncology setting. Methods: Atwo-phase convergent parallel mixed methods study. Patient participants who met any of the “Royal Marsden Triggers Tool” criteria were compared with those who did not in terms of demographic data, palliative care needs (Integrated Palliative Outcome Scale, IPOS) and quality of life indicators (EORTC-QLQ-C30). In-depth interviews were carried out with patients and oncology staff about their views and experience of the “Royal Marsden Triggers tool”. Qualitative and quantitative data were triangulated at data interpretation. Results: 348 patients were recruited to the quantitative phase of the study of whom 53% met at least one of the Triggers tool palliative care referral criteria. When compared with patients who were negative using the Triggers tool, “Royal Marsden Triggers tool” positive patients had a lower quality of life (EORTC QLQ-C30 Global Health Status scale (p<0.01)) and a higher proportion had severe or overwhelming physical needs on IPOS (38% versus 20%, p<0.001). Median survival of “Royal Marsden Triggers tool” positive patients was 11.7 months. 16 staff and 19 patients participated in qualitative interviews. The use of the tool normalized palliative care involvement, supporting individualized care and access to appropriate expertise. Conclusion The use of a palliative care referral tool streamlines palliative care within oncology outpatient services and supports teams working together to provide an early holistic patient-centered service. Further research is needed to evaluate the effectiveness and feasibility of this approach.

  • Open Access

    Advance care planning before and during the COVID-19 pandemic: an observational cohort study of 73 675 patients’ records

    by Philippa G McFarlane, Catey Bunce, Katherine E Sleeman, Martina Orlovic, Jonathan Koffman, John Rosling, Alastair Bearne, Margaret Powell, Julia Riley, Joanne Droney

    Background: Advance care planning (ACP) was encouraged by policymakers throughout the COVID-19 pandemic. Little is known about use of ACP during this time. Aim: To compare use of ACP before and during the COVID-19 pandemic. Design & setting: Retrospective, observational cohort study comparing the creation, use, and content of Electronic Palliative Care Coordination System (EPaCCS) records in London. Individuals aged ≥18 years with a Coordinate My Care record, created and published in the pre-pandemic period (1 January 2018–31 December 2019), wave 1 (W1; 20 March 2020–4 July 2020), interwave (IW; 5 July 2020–30 September 2020), and wave 2 (W2; 1 October 2020–5 March 2021). Method: Patient demographics and components of ACP were compared using descriptive and comparative statistics. Results: In total, 73 675 records were included; 35 108 pre-pandemic, 21 235 W1, 6323 IW, and 9925 W2 ( n = 1084 records not stratified as created and published in different periods). Most records were created in primary care (55.6% pre-pandemic, 75.5% W1, and 47.7% W2). Compared with the pre-pandemic period, the average weekly number of records created increased by 296.9% W1 ( P P P P P <0.005]). Conclusion: During the COVID-19 pandemic increased ACP activity was observed, especially in primary care, for younger people and those not imminently dying. Further research is needed to identify training and planning requirements as well as organisational and system changes to support sustained high-quality ACP within primary care.


  • Open Access

    Digital advance care planning with severe mental illness: a retrospective observational cohort analysis of the use of an electronic palliative care coordination system

    by Rea Kaur Gill, Joanne Droney, Gareth Owen, Julia Riley, Lucy Stephenson

    Background: People living with severe mental illness (SMI) face significant health inequalities, including in palliative care. Advance Care Planning (ACP) is widely recommended by palliative care experts and could reduce inequalities. However, implementing ACP with this group is challenging. Electronic Palliative Care Coordination Systems such as Coordinate my Care (CMC) have been introduced to support documentation and sharing of ACP records with relevant healthcare providers. This study explores the use of CMC amongst those with SMI and aims to describe how those with a primary diagnosis of SMI who have used CMC for ACP, and makes recommendations for future research and policy. Method: A retrospective observational cohort analysis was completed of CMC records created 01/01/2010–31/09/2021 where the service user had a primary diagnosis of SMI, with no exclusions based on comorbidities. Descriptive statistics were used to report on characteristics including: age, diagnosis, individual prognosis and resuscitation status. Thematic analysis was used to report on the content of patients’ statements of preference. Results: 1826 records were identified. Of this sample most (60.1%) had capacity to make treatment decisions, 47.8% were aged under 70, 86.7% were given a prognosis of ‘years’ and most (63.1%) remained for full cardio-pulmonary resuscitation in the event of cardio-pulmonary arrest. Records with completed statements of preferences (20.3%) contained information about preferences for physical and mental health treatment care as well as information about patient presentation and capacity, although most were brief and lacked expression of patient voice. Discussion: Compared to usual CMC users, the cohort of interest are relatively able, younger people using CMC to make long-term plans for active physical and mental health treatment. ADM is a service user-driven process, and so it was expected that authentic patient voice would be expressed within statements of preference, however this was mostly not achieved. Conclusions: This digital tool is being used by people with SMI but to plan for more than palliative care. This cohort and supporting professionals have used CMC to plan for longer term physical and mental healthcare. Future research and policy should focus on development of tailored digital tools for people with SMI to plan for palliative, physical and mental healthcare and support expression of patient voice.


  • Palliation at End of Life

    by Joanne Droney, Phoebe Wright, Dola Awoyemi

  • Open Access

    Accuracy of clinical predictions of prognosis at the end-of-life: evidence from routinely collected data in urgent care records

    by M. Orlovic, J. Droney, V. Vickerstaff, J. Rosling, A. Bearne, M. Powell, J. Riley, P. McFarlane, J. Koffman, P. Stone

    Background: The accuracy of prognostication has important implications for patients, families, and health services since it may be linked to clinical decision-making, patient experience and outcomes and resource allocation. Study aim is to evaluate the accuracy of temporal predictions of survival in patients with cancer, dementia, heart, or respiratory disease. Methods: Accuracy of clinical prediction was evaluated using retrospective, observational cohort study of 98,187 individuals with a Coordinate My Care record, the Electronic Palliative Care Coordination System serving London, 2010–2020. The survival times of patients were summarised using median and interquartile ranges. Kaplan Meier survival curves were created to describe and compare survival across prognostic categories and disease trajectories. The extent of agreement between estimated and actual prognosis was quantified using linear weighted Kappa statistic. Results: Overall, 3% were predicted to live “days”; 13% “weeks”; 28% “months”; and 56% “year/years”. The agreement between estimated and actual prognosis using linear weighted Kappa statistic was highest for patients with dementia/frailty (0.75) and cancer (0.73). Clinicians’ estimates were able to discriminate (log-rank p < 0.001) between groups of patients with differing survival prospects. Across all disease groups, the accuracy of survival estimates was high for patients who were likely to live for fewer than 14 days (74% accuracy) or for more than one year (83% accuracy), but less accurate at predicting survival of “weeks” or “months” (32% accuracy). Conclusion: Clinicians are good at identifying individuals who will die imminently and those who will live for much longer. The accuracy of prognostication for these time frames differs across major disease categories, but remains acceptable even in non-cancer patients, including patients with dementia. Advance Care Planning and timely access to palliative care based on individual patient needs may be beneficial for those where there is significant prognostic uncertainty; those who are neither imminently dying nor expected to live for “years”.


  • Open Access

    Advance Care Planning and Place of Death During the COVID-19 Pandemic: A Retrospective Analysis of Routinely Collected Data

    by Philippa McFarlane, Katherine E Sleeman, Catey Bunce, Jonathan Koffman, Martina Orlovic, John Rosling, Alastair Bearne, Margaret Powell, Julia Riley, Joanne Droney

    Increased advance care planning was endorsed at the start of the Coronavirus disease 2019 (COVID-19) pandemic with the aim of optimizing end-of-life care. This retrospective observational cohort study explores the impact of advanced care planning on place of death. 21,962 records from patients who died during the first year of the pandemic and who had an Electronic Palliative Care Coordination System record were included. 11,913 (54%) had a documented place of death. Of these 5,339 died at home and 2,378 died in hospital. 9,971 (45%) had both a documented place of death and a preferred place of death. Of these, 7,668 (77%) died in their preferred location. Documented elements of advance care planning, such as resuscitation status and ceiling of treatment decisions, were associated with an increased likelihood of dying in the preferred location, as were the number of times the record was viewed. During the COVID-19 pandemic, advanced care planning and the use of digital care coordination systems presented an opportunity for patients and healthcare staff to personalize care and influence end-of-life experiences.


  • Open Access

    Healthcare use and cost trajectories during the last year of life: A national population administrative secondary care data linkage study

    by Katharina Diernberger, Xhyljeta Luta, Joanna Bowden, Marie Fallon, Joanne Droney, Elizabeth Lemmon, Ewan Gray, Joachim Marti, Peter S Hall

    Background: People who are nearing the end of life are high users of healthcare. The cost to providers is high and the value of care is uncertain. Objectives: To describe the pattern, trajectory and drivers of secondary care use and cost by people in Scotland in their last year of life. Methods: Retrospective whole-population secondary care administrative data linkage study of Scottish decedents of 60 years and over between 2012 and 2017 (N=274,048). Results: Secondary care use was high in the last year of life with a sharp rise in inpatient admissions in the last three months. The mean cost was £10,000. Cause of death was associated with differing patterns of healthcare use: dying of cancer was preceded by the greatest number of hospital admissions and dementia the least. Greater age was associated with lower admission rates and cost. There was higher resource use in the urban areas. No difference was observed by deprivation. Conclusions: Hospitalisation near the end of life was least frequent for older people and those living rurally, although length of stay for both groups, when they were admitted, was longer. Research is required to understand if variation in hospitalisation is due to variation in the quantity or quality of end of life care available, varying community support, patient preferences or an inevitable consequence of disease-specific needs.


  • Open Access

    Managing uncertain recovery for patients nearing the end of life in hospital: a mixed-methods feasibility cluster randomised controlled trial of the AMBER care bundle

    by J. Koffman, E. Yorganci, D. Yi, W. Gao, F. Murtagh, A. Pickles, S. Barclay, H. Johnson, R. Wilson, L. Sampson, et al.

    The AMBER (Assessment, Management, Best Practice, Engagement, Recovery Uncertain) care bundle is a complex intervention used in UK hospitals to support patients with uncertain recovery. However, it has yet to be evaluated in a randomised controlled trial (RCT) to identify potential benefits or harms. The aim of this trial was to investigate the feasibility of a cluster RCT of the AMBER care bundle. This is a prospective mixed-methods feasibility cluster RCT. Quantitative data collected from patients (or proxies if patients lack capacity) were used (i) to examine recruitment, retention and follow-up rates; (ii) to test data collection tools for the trial and determine their optimum timing; (iii) to test methods to identify the use of financial resources; and (iv) to explore the acceptability of study procedures for health professionals and patients. Descriptive statistical analyses and thematic analysis used the framework approach. In total, 894 patients were screened, of whom 220 were eligible and 19 of those eligible (8.6%) declined to participate. Recruitment to the control arm was challenging. Of the 728 patients screened for that arm, 647 (88.9%) were excluded. Overall, 65 patients were recruited (81.3% of the recruitment target of 80). Overall, many were elderly (≥80 years, 46.2%, n = 30, mean = 77.8 years, standard deviation [SD] = 12.3 years). Over half (53.8%) had a non-cancer diagnosis, with a mean of 2.3 co-morbidities; 24.6% patients (n = 16) died during their hospital stay and 35.4% (n = 23) within 100 days of discharge. In both trial arms, baseline IPOS subscale scores identified moderate patient anxiety (control: mean 13.3, SD 4.8; intervention: mean 13.3, SD 5.1), and howRwe identified a good care experience (control: mean 13.1, SD 2.5; intervention: mean 11.5, SD 2.1). Collecting quantitative service use and quality of life data was feasible. No patient participants regarded study involvement negatively. Focus groups with health professionals identified concerns regarding (i) the subjectivity of the intervention’s eligibility criteria, (ii) the need to prognosticate to identify potential patients and (iii) consent procedures and the length of the questionnaire. A full trial of the AMBER care bundle is technically feasible but impractical due to fundamental issues in operationalising the intervention’s eligibility criteria, which prevents optimal recruitment. Since this complex intervention continues to be used in clinical care and advocated in policy, alternative research approaches must be considered and tested. International Standard Randomised Controlled Trial Number (ISRCTN) Register, ISRCTN36040085 .